EE200100368A - w-Carboxyaryl-substituted diphenylureas as raf kinase inhibitors - Google Patents

w-Carboxyaryl-substituted diphenylureas as raf kinase inhibitors

Info

Publication number: EE200100368A
Authority: EE; Estonia
Prior art keywords: diphenylureas; carboxyaryl; substituted; kinase inhibitors; raf kinase
Prior art date: 1999-01-13

Application number

EEP200100368A

Other languages

Estonian (et)

Inventor

Elizabeth Wood Jill

Riedl Bernd

Dumas Jacques

Khire Uday

B. Lowinger Timothy

J. Scott William

A. Smith Roger

Monahan Mary-Katherine

Natero Reina

Renick Joel

N. Sibley Robert

Original Assignee

Bayer Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-13

Filing date

2000-01-12

Publication date

2003-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27381740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200100368(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-01-12 Application filed by Bayer Corporation filed Critical Bayer Corporation

2000-01-12 Priority claimed from PCT/US2000/000648 external-priority patent/WO2000042012A1/en

2003-04-15 Publication of EE200100368A publication Critical patent/EE200100368A/en

2007-10-15 Publication of EE04913B1 publication Critical patent/EE04913B1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C275/36—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with at least one of the oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. N-aryloxyphenylureas
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/50—Iso-indoles; Hydrogenated iso-indoles with oxygen and nitrogen atoms in positions 1 and 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Environmental Sciences (AREA)
Zoology (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Plant Pathology (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Furan Compounds (AREA)
Pyrrole Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

EEP200100368A 1999-01-13 2000-01-12 Omega-carboxylated diphenyl ureas as RAF kinase inhibitors and pharmaceutical compositions containing them EE04913B1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US11587799P	1999-01-13	1999-01-13
US25726699A	1999-02-25	1999-02-25
US42522899A	1999-10-22	1999-10-22
PCT/US2000/000648 WO2000042012A1 (en)	1999-01-13	2000-01-12	φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS

Publications (2)

Publication Number	Publication Date
EE200100368A true EE200100368A (en)	2003-04-15
EE04913B1 EE04913B1 (en)	2007-10-15

Family

ID=27381740

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100368A EE04913B1 (en)	1999-01-13	2000-01-12	Omega-carboxylated diphenyl ureas as RAF kinase inhibitors and pharmaceutical compositions containing them

Country Status (40)

Country	Link
JP (2)	JP3845792B2 (en)
KR (3)	KR101091101B1 (en)
CN (2)	CN1219764C (en)
AR (1)	AR035310A1 (en)
AT (2)	ATE321027T1 (en)
AU (1)	AU2501600A (en)
BG (1)	BG65945B1 (en)
BR (2)	BRPI0007487B8 (en)
CA (1)	CA2359510C (en)
CU (1)	CU23213A3 (en)
CY (2)	CY2200149T2 (en)
CZ (2)	CZ299125B6 (en)
DE (4)	DE60044004D1 (en)
DK (1)	DK1140840T3 (en)
DZ (1)	DZ3004A1 (en)
EE (1)	EE04913B1 (en)
EG (1)	EG24407A (en)
ES (2)	ES2255971T3 (en)
GT (2)	GT200000002AA (en)
HK (2)	HK1045504B (en)
HR (1)	HRP20010580B1 (en)
HU (2)	HU225780B1 (en)
IL (2)	IL144030A0 (en)
JO (1)	JO2373B1 (en)
LU (1)	LU91280I2 (en)
MA (1)	MA26038A1 (en)
ME (1)	MEP36908A (en)
MY (1)	MY138897A (en)
NL (1)	NL300242I2 (en)
NO (3)	NO321059B1 (en)
NZ (1)	NZ556598A (en)
PA (1)	PA8489701A1 (en)
PL (1)	PL215029B1 (en)
PT (2)	PT1140840E (en)
RS (1)	RS51497B (en)
SK (2)	SK287419B6 (en)
SV (1)	SV2001000004A (en)
TN (1)	TNSN00010A1 (en)
TR (1)	TR200102020T2 (en)
TW (1)	TWI269791B (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1580188B9 (en)	2002-02-11	2012-05-23	Bayer HealthCare, LLC	Aryl ureas as kinase inhibitors
TW200406374A (en) *	2002-05-29	2004-05-01	Novartis Ag	Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
US20070161677A1 (en) *	2004-01-30	2007-07-12	Merck Patent Gmbh	Bisarylurea derivatives
TW200530236A (en) *	2004-02-23	2005-09-16	Chugai Pharmaceutical Co Ltd	Heteroaryl phenylurea
MY191349A (en) *	2004-08-27	2022-06-17	Bayer Pharmaceuticals Corp	New pharmaceutical compositions for the treatment of hyper-proliferative disorders
SG155997A1 (en) *	2004-09-29	2009-10-29	Bayer Schering Pharma Ag	Process for the preparation of 4-{4-[({[4-chloro-3- (trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-n- methylpyridine-2-carboxamide
DE102005015253A1 (en) *	2005-04-04	2006-10-05	Merck Patent Gmbh	New pyrazole derivatives are tyrosine kinase inhibitors useful to treat e.g. solid tumors, diabetic retinopathy, age-related macular degeneration or inflammatory disease, osteoarthritis and rickets
US8580798B2 (en)	2005-12-21	2013-11-12	Bayer Intellectual Property Gmbh	Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
WO2008044688A1 (en) *	2006-10-11	2008-04-17	Daiichi Sankyo Company, Limited	Urea derivative
EP2136809A4 (en) *	2007-03-20	2012-01-04	Curis Inc	Raf kinase inhibitors containing a zinc binding moiety
WO2009034308A2 (en) *	2007-09-10	2009-03-19	Cipla Limited	Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
CN101372475B (en) *	2008-03-19	2012-01-04	南京工业大学	Aromatic heterocyclic substituted diphenyl urea derivative and application thereof
CN101298427B (en) *	2008-06-26	2012-03-21	中国科学院广州生物医药与健康研究院	Diaryl urea compound and use thereof
TW201012467A (en)	2008-09-16	2010-04-01	Taiho Pharmaceutical Co Ltd	Antitumor agent containing 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic acid
CN103254126A (en) *	2008-09-19	2013-08-21	苏州泽璟生物制药有限公司	Deuterated omega-diphenyl carbamide as well as derivative and pharmaceutical composition including compounds
CN101362717B (en) *	2008-09-28	2013-02-06	四川大学	4-(4-aminoanilino)-2-(methylcarbamoyl)pyridine and its derivatives, their preparation method and use
JO3101B1 (en) *	2008-12-02	2017-09-20	Takeda Pharmaceuticals Co	Benzothiazole derivatives as anticancer agents
WO2010083649A1 (en) *	2009-01-22	2010-07-29	沈阳药科大学	Bisarylurea derivatives and their use
JP5728499B2 (en) *	2010-02-05	2015-06-03	アイアールエム・リミテッド・ライアビリティ・カンパニーＩｒｍ，Ｌｌｃ	Compounds and compositions as protein kinase inhibitors
CN102219733A (en) *	2010-04-14	2011-10-19	上海医药工业研究院	Method for preparing sorafenib
CN102617458A (en) *	2010-05-18	2012-08-01	张南	Preparation method for anticancer compound
CN101830847B (en) *	2010-05-18	2012-10-10	张南	Anticancer compound and preparation method thereof
UA112163C2 (en) *	2010-10-01	2016-08-10	Байєр Інтеллектуал Проперті Гмбх	COMBINATIONS CONTAINING SUBSTITUTED N- (2-ARYLAMINO) ARYLSULPHONAMIDE
CA2824028A1 (en) *	2011-01-06	2012-07-12	Beta Pharma Canada Inc.	Novel ureas for the treatment and prevention of cancer
CN102875460A (en) *	2012-05-17	2013-01-16	上海奥博生物医药技术有限公司	Method for preparing sorafenib
CN103508961B (en) *	2012-06-26	2015-07-22	中美冠科生物技术（太仓）有限公司	Antitumor drug
CN103408488A (en) *	2013-08-13	2013-11-27	张家港威胜生物医药有限公司	Optimal synthetic method of sorafenib
CN103435553A (en) *	2013-09-16	2013-12-11	中国药科大学	Piperazine structure-based aryl formamide Raf kinase inhibitor and preparation method as well as application thereof
CN104672129B (en) *	2013-11-26	2019-06-25	广东东阳光药业有限公司	A kind of preparation method of carbamide compounds
CN106866623A (en) *	2014-04-08	2017-06-20	北大方正集团有限公司	Polysubstituted pyridine compounds, preparation method, purposes and pharmaceutical composition
CN104177292A (en) *	2014-08-08	2014-12-03	亿腾药业（泰州）有限公司	Method for industrial production of sorafenib tosylate polymorphic form I
US20170273922A1 (en) *	2014-10-03	2017-09-28	The Royal Institution For The Advacement Of Learning/Mcgill University	Urea and bis-urea based compounds and analogues thereof useful in the treatment of androgen receptor mediated diseases or disorders
CN105348186B (en) *	2015-10-15	2018-05-22	青岛海洋生物医药研究院股份有限公司	Deuterated substituted bisarylurea compound and preparation method thereof and the application in anti-tumor drug is prepared
CN105753841B (en) *	2016-01-18	2018-01-05	西安交通大学	A kind of N indazoles substituting thioureido analog derivative and its preparation method and application
CN105924390B (en) *	2016-05-19	2018-07-10	广州南新制药有限公司	A kind of synthetic method of Mei Tafeini
CN106699652B (en) *	2016-11-07	2020-11-13	天津大学	Sorafenib alpha-aminobutyrate and preparation method thereof
CN108264510A (en)	2017-01-02	2018-07-10	上海喆邺生物科技有限公司	A kind of selective depression kinases compound and application thereof
CN107417604A (en) *	2017-07-25	2017-12-01	新发药业有限公司	Benzamide compound of 4 substituted pyridines 2 and preparation method and application
CA3132855A1 (en) *	2019-04-12	2020-10-15	National Health Research Institutes	Heterocyclic compounds as kinase inhibitors for therapeutic uses
CN113831491B (en) *	2021-09-30	2023-03-24	南昌大学	Preparation method and adsorption application of pyrimidazole covalent organic framework

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4973675A (en) *	1989-04-13	1990-11-27	University Of Tennessee Research Center	Hybrid nitrosoureidoanthracyclines having antitumor activity
US5447987A (en) *	1993-12-24	1995-09-05	Shin-Etsu Chemical Co., Ltd.	Organopolysiloxane compositions
WO1995033458A1 (en) *	1994-06-02	1995-12-14	Smithkline Beecham Corporation	Anti-inflammatory compounds
US5447957A (en) *	1994-06-02	1995-09-05	Smithkline Beecham Corp.	Anti-inflammatory compounds
EP0986382B1 (en) *	1997-05-23	2008-06-25	Bayer Pharmaceuticals Corporation	Raf kinase inhibitors
WO1998052558A1 (en) *	1997-05-23	1998-11-26	Bayer Corporation	INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
WO1999020617A1 (en) *	1997-10-21	1999-04-29	Active Biotech Ab	Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
IL136690A0 (en) *	1997-12-22	2001-06-14	Bayer Ag	Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas

2000
- 2000-01-12 TN TNTNSN00010A patent/TNSN00010A1/en unknown
- 2000-01-12 PT PT00903239T patent/PT1140840E/en unknown
- 2000-01-12 GT GT200000002AK patent/GT200000002AA/en unknown
- 2000-01-12 TR TR2001/02020T patent/TR200102020T2/en unknown
- 2000-01-12 EE EEP200100368A patent/EE04913B1/en active Protection Beyond IP Right Term
- 2000-01-12 ES ES00903239T patent/ES2255971T3/en not_active Expired - Lifetime
- 2000-01-12 CN CNB008026858A patent/CN1219764C/en not_active Expired - Lifetime
- 2000-01-12 AT AT00903239T patent/ATE321027T1/en active
- 2000-01-12 SV SV2000000004A patent/SV2001000004A/en active IP Right Grant
- 2000-01-12 SK SK5096-2006A patent/SK287419B6/en not_active IP Right Cessation
- 2000-01-12 PA PA20008489701A patent/PA8489701A1/en unknown
- 2000-01-12 CZ CZ20012489A patent/CZ299125B6/en not_active IP Right Cessation
- 2000-01-12 CZ CZ20060706A patent/CZ302846B6/en not_active IP Right Cessation
- 2000-01-12 DE DE60044004T patent/DE60044004D1/en not_active Expired - Lifetime
- 2000-01-12 IL IL14403000A patent/IL144030A0/en unknown
- 2000-01-12 JP JP2000593580A patent/JP3845792B2/en not_active Expired - Lifetime
- 2000-01-12 RS YUP-491/01A patent/RS51497B/en unknown
- 2000-01-12 DK DK00903239T patent/DK1140840T3/en active
- 2000-01-12 GT GT200000002A patent/GT200000002A/en unknown
- 2000-01-12 DE DE2000626822 patent/DE122006000059I1/en active Pending
- 2000-01-12 HU HU0300866A patent/HU225780B1/en active Protection Beyond IP Right Term
- 2000-01-12 BR BRPI0007487A patent/BRPI0007487B8/en not_active IP Right Cessation
- 2000-01-12 AU AU25016/00A patent/AU2501600A/en not_active Abandoned
- 2000-01-12 SK SK988-2001A patent/SK285532B6/en not_active IP Right Cessation
- 2000-01-12 KR KR1020117012056A patent/KR101091101B1/en not_active Expired - Lifetime
- 2000-01-12 DZ DZ000006A patent/DZ3004A1/en active
- 2000-01-12 HU HU0600871A patent/HU230863B1/en unknown
- 2000-01-12 AT AT05028442T patent/ATE460398T1/en active
- 2000-01-12 PL PL386517A patent/PL215029B1/en unknown
- 2000-01-12 KR KR1020077002656A patent/KR20070020158A/en not_active Ceased
- 2000-01-12 BR BRPI0017535A patent/BRPI0017535B8/en not_active IP Right Cessation
- 2000-01-12 NZ NZ556598A patent/NZ556598A/en not_active IP Right Cessation
- 2000-01-12 DE DE05028442T patent/DE05028442T1/en active Pending
- 2000-01-12 ME MEP-369/08A patent/MEP36908A/en unknown
- 2000-01-12 PT PT05028442T patent/PT1690853E/en unknown
- 2000-01-12 ES ES05028442T patent/ES2272203T3/en not_active Expired - Lifetime
- 2000-01-12 CN CNB2005100895046A patent/CN100522934C/en not_active Expired - Lifetime
- 2000-01-12 DE DE60026822T patent/DE60026822T2/en not_active Expired - Lifetime
- 2000-01-12 CA CA002359510A patent/CA2359510C/en not_active Expired - Lifetime
- 2000-01-12 KR KR1020017008847A patent/KR100719166B1/en not_active Expired - Lifetime
- 2000-01-13 JO JO20003A patent/JO2373B1/en active
- 2000-01-13 AR ARP000100153A patent/AR035310A1/en active IP Right Grant
- 2000-01-13 MY MYPI20000102A patent/MY138897A/en unknown
- 2000-01-15 EG EG20000039A patent/EG24407A/en active
- 2000-04-07 TW TW089100575A patent/TWI269791B/en not_active IP Right Cessation
2001
- 2001-06-27 IL IL144030A patent/IL144030A/en not_active IP Right Cessation
- 2001-07-12 NO NO20013463A patent/NO321059B1/en not_active IP Right Cessation
- 2001-07-13 CU CU20010168A patent/CU23213A3/en unknown
- 2001-08-02 HR HR20010580A patent/HRP20010580B1/en not_active IP Right Cessation
- 2001-08-06 MA MA26289A patent/MA26038A1/en unknown
2002
- 2002-09-20 HK HK02106872.8A patent/HK1045504B/en not_active IP Right Cessation
2005
- 2005-12-09 NO NO20055863A patent/NO337326B1/en not_active IP Right Cessation
2006
- 2006-07-11 JP JP2006190034A patent/JP4472669B2/en not_active Expired - Lifetime
- 2006-07-13 HK HK06107837.6A patent/HK1087689A1/en not_active IP Right Cessation
- 2006-09-26 BG BG109688A patent/BG65945B1/en unknown
- 2006-10-12 NL NL300242C patent/NL300242I2/en unknown
- 2006-10-13 LU LU91280C patent/LU91280I2/en unknown
2007
- 2007-01-05 NO NO2007002C patent/NO2007002I2/en unknown
- 2007-01-15 CY CY20072200001T patent/CY2200149T2/en unknown
2010
- 2010-06-10 CY CY20101100512T patent/CY1110177T1/en unknown

Also Published As

Publication number	Publication date
MY138897A (en)	2009-08-28
KR101091101B1 (en)	2011-12-09
HK1045504A1 (en)	2002-11-29
HK1087689A1 (en)	2006-10-20
SK285532B6 (en)	2007-03-01
SK9882001A3 (en)	2002-04-04
BG65945B1 (en)	2010-06-30
HK1045504B (en)	2006-04-07
PT1140840E (en)	2006-05-31
BRPI0007487B8 (en)	2021-05-25
GT200000002AA (en)	2007-06-15
PA8489701A1 (en)	2002-11-18
YU49101A (en)	2004-05-12
NZ556598A (en)	2008-11-28
DE122006000059I1 (en)	2007-02-15
DE60026822D1 (en)	2006-05-11
HRP20010580A2 (en)	2002-08-31
CZ299125B6 (en)	2008-04-30
ES2272203T1 (en)	2007-05-01
EE04913B1 (en)	2007-10-15
ES2255971T3 (en)	2006-07-16
NO20055863L (en)	2001-09-12
BRPI0017535B1 (en)	2018-02-14
AU2501600A (en)	2000-08-01
DZ3004A1 (en)	2004-03-27
DK1140840T3 (en)	2006-07-31
MEP36908A (en)	2011-02-10
EG24407A (en)	2009-05-20
CZ302846B6 (en)	2011-12-14
HUP0300866A2 (en)	2003-07-28
GT200000002A (en)	2002-01-09
CY2200149T2 (en)	2010-07-28
BR0007487A (en)	2003-09-23
CU23213A3 (en)	2007-06-20
SV2001000004A (en)	2001-01-10
PL360085A1 (en)	2004-09-06
IL144030A (en)	2010-06-30
HUP0300866A3 (en)	2006-04-28
CA2359510C (en)	2007-02-13
AR035310A1 (en)	2004-05-12
DE60044004D1 (en)	2010-04-22
BRPI0007487B1 (en)	2015-07-07
TNSN00010A1 (en)	2002-05-30
NO20013463L (en)	2001-09-12
ATE460398T1 (en)	2010-03-15
KR20070020158A (en)	2007-02-16
CN100522934C (en)	2009-08-05
KR20110063595A (en)	2011-06-10
NO2007002I2 (en)	2009-10-05
NL300242I2 (en)	2007-04-02
LU91280I2 (en)	2006-12-13
CN1341098A (en)	2002-03-20
CN1721397A (en)	2006-01-18
LU91280I9 (en)	2019-01-02
HU225780B1 (en)	2007-08-28
IL144030A0 (en)	2002-04-21
CA2359510A1 (en)	2000-07-20
NO337326B1 (en)	2016-03-07
DE60026822T2 (en)	2006-08-24
HU0600871D0 (en)	2007-01-29
JP2006328075A (en)	2006-12-07
MA26038A1 (en)	2004-04-01
PL215029B1 (en)	2013-10-31
CZ20012489A3 (en)	2002-01-16
JP3845792B2 (en)	2006-11-15
ATE321027T1 (en)	2006-04-15
NO321059B1 (en)	2006-03-06
CN1219764C (en)	2005-09-21
ES2272203T3 (en)	2010-07-13
BRPI0017535B8 (en)	2021-09-14
KR20010103738A (en)	2001-11-23
TWI269791B (en)	2007-01-01
HRP20010580B1 (en)	2010-07-31
KR100719166B1 (en)	2007-05-17
HU230863B1 (en)	2018-10-29
JP2003526613A (en)	2003-09-09
TR200102020T2 (en)	2003-01-21
PT1690853E (en)	2010-04-23
JO2373B1 (en)	2006-12-12
BG109688A (en)	2007-05-31
SK287419B6 (en)	2010-09-07
DE05028442T1 (en)	2007-02-22
JP4472669B2 (en)	2010-06-02
RS51497B (en)	2011-04-30
NO2007002I1 (en)	2007-01-05
CY1110177T1 (en)	2015-01-14
NO20013463D0 (en)	2001-07-12
NL300242I1 (en)	2006-12-01

Publication	Publication Date	Title
EE200100368A (en)	2003-04-15	w-Carboxyaryl-substituted diphenylureas as raf kinase inhibitors
CY2007002I1 (en)	2009-11-04	O-CARBOXYARYLIPOCUTATED BIFINYLUREAS AS RAF KINASE INHIBITORS
EE200200140A (en)	2003-04-15	Pteridinones as kinase inhibitors
NO20021820D0 (en)	2002-04-18	Tyrosine kinase inhibitors
EE05432B1 (en)	2011-06-15	P rrolop rimidines as protein kinase inhibitors
ID30460A (en)	2001-12-06	INHIBITORS, INHIBITORS, THYROCIN CINASE PROTEIN
ATE318603T1 (en)	2006-03-15	PYRROLOTRIAZINE KINASE INHIBITORS
DE60128709D1 (en)	2007-07-12	TRIAZOL COMPOUNDS AS PROTEIN KINASE INHIBITORS
EE200100268A (en)	2002-12-16	Substituted pyrazoles as p38 kinase inhibitors
ATE505471T1 (en)	2011-04-15	AZAINDOL KINASE INHIBITORS
HK1049154A1 (en)	2003-05-02	2-pyrazolin-5-ones as tyrosine kinase inhibitors
DE60008527D1 (en)	2004-04-01	CELL POLLIFERATION INHIBITORS
NO20023013D0 (en)	2002-06-21	Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
EE200300266A (en)	2003-10-15	Substituted 8-arylquinolines as phosphodiesterase-4 inhibitors
NO20025659L (en)	2002-11-25	Heterocyclic compounds
DK1690853T3 (en)	2010-06-07	Omega-carboxyaryl-substituted diphenylureas for use as raf kinase inhibitors
SI1318992T1 (en)	2005-12-31	Imidazole derivatives as raf kinase inhibitors
DK1226136T3 (en)	2005-04-25	tyrosine kinase
IDP000027420A (en)	2001-12-20	PYROLOTRIAZIN INHIBITOR INHIBITORS

Legal Events

Date	Code	Title	Description
2008-02-15	AA1Y	Spc filed	Free format text: PRODUCT NAME: NEXAVAR-SORAFENIB; REG NO/DATE: 19.07.2006 K(2006)3362 Spc suppl protection certif: C20070005 Filing date: 20071206
2008-02-15	FG1Y	Spc granted	Free format text: PRODUCT NAME: NEXAVAR-SORAFENIB; REG NO/DATE: 19.07.2006 K(2006)3362 Spc suppl protection certif: C20070005 00015 Filing date: 20071206 Extension date: 20210721
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-12-15	GB1A	Change in the ownership or in the address of the owner
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2019-08-15	HE1A	Change of address
2019-08-15	SPCT	Party data change related to a supplementary protection certificate	Free format text: TZ1Y, PARTY DATA CHANGE RELATED TO A GRANTED SPC Spc suppl protection certif: C20070015